Beigelman L, Karpeisky A, Matulic-Adamic J, Haeberli P, Sweedler D, Usman N
Department of Chemistry and Biochemistry, Ribozyme Pharmaceuticals Inc., Boulder, CO 80301, USA.
Nucleic Acids Res. 1995 Nov 11;23(21):4434-42. doi: 10.1093/nar/23.21.4434.
Several 2'-modified ribonucleoside phosphoramidites have been prepared for structure-activity studies of the hammerhead ribozyme. The aim of these studies was to design and synthesize catalytically active and nuclease-resistant ribozymes. Synthetic schemes for stereoselective synthesis of the R isomer of 2'-deoxy-2'-C-allyl uridine and cytidine phosphoramidites, based on the Keck allylation procedure, were developed. Protection of the 2'-amino group in 2'-deoxy-2'-aminouridine was optimized and a method for the convenient preparation of 5'-O-dimethoxytrityl-2'-deoxy-2'-phthalimidouridine 3'-O-(2-cyanoethyl-N,N-diisopropylphosphoramidite) was developed. During the attempted preparation of the 2'-O-t-butyldimethylsilyl-3'-O-phosphoramidite of arabinouridine a reversed regioselectivity in the silylation reaction, compared with the published procedure, was observed, as well as the unexpected formation of the 2,2'-anhydronucleoside. A possible mechanism for this cyclization is proposed. The synthesis of 2'-deoxy-2'-methylene and 2'-deoxy-2'-difluoromethylene uridine phosphoramidites is described. Based on a '5-ribose' model for essential 2'-hydroxyls in the hammerhead ribozyme these 2'-modified monomers were incorporated at positions U4 and/or U7 of the catalytic core. A number of these ribozymes had almost wild-type catalytic activity and improved stability in human serum, compared with an all-RNA molecule.
为了对锤头状核酶进行构效关系研究,已制备了几种2'-修饰的核糖核苷亚磷酰胺。这些研究的目的是设计并合成具有催化活性且抗核酸酶的核酶。基于Keck烯丙基化方法,开发了立体选择性合成2'-脱氧-2'-C-烯丙基尿苷和胞苷亚磷酰胺R异构体的合成方案。优化了2'-脱氧-2'-氨基尿苷中2'-氨基的保护,并开发了一种方便制备5'-O-二甲氧基三苯甲基-2'-脱氧-2'-邻苯二甲酰亚氨基尿苷3'-O-(2-氰基乙基-N,N-二异丙基亚磷酰胺)的方法。在尝试制备阿拉伯糖核苷的2'-O-叔丁基二甲基甲硅烷基-3'-O-亚磷酰胺时,观察到与已发表方法相比,硅烷化反应中的区域选择性发生了反转,同时意外形成了2,2'-脱水核苷。提出了这种环化反应的一种可能机制。描述了2'-脱氧-2'-亚甲基和2'-脱氧-2'-二氟亚甲基尿苷亚磷酰胺的合成。基于锤头状核酶中必需的2'-羟基的“5-核糖”模型,将这些2'-修饰的单体掺入催化核心的U4和/或U7位置。与全RNA分子相比,许多此类核酶具有几乎野生型的催化活性,并在人血清中具有更高的稳定性。